Brief: Eurocine Vaccines Deepens Cooperation With Spixia Biotechnology
May 29 (Reuters) - Eurocine Vaccines AB EUCI.TE :
* SAID ON THURSDAY DEEPENS COOPERATION WITH SPIXIA
BIOTECHNOLOGY
THROUGH MORE DETAILED LOI
* THE TERMS WILL NOT BE BINDING ON THE PARTIES UNTIL A FINAL
RESEARCH AND COLLABORATION AGREEMENT IS CONCLUDED, WHICH IS
EXPECTED TO TAKE PLACE BEFORE MID-YEAR 2020
Source text for Eikon: urn:newsml:reuters.com:*:nWkr50fdLS
Further company coverage: [ EUCI.TE ]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate